2096.HK
2096.HK
HK0000658531
SIMCERE PHARMA
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 7.731.411.000 6.635.211.000
16.5%
Cost of Revenue 1.421.555.000 1.310.632.000
8.5%
Gross Profit 6.309.856.000 5.324.579.000
18.5%
4.915.419.000 4.231.855.000
16.2%
Operating Income 1.394.437.000 1.092.724.000
27.6%
Pretax Income 1.514.330.000 808.715.000
87.3%
Net Income Common Stockholders 1.344.008.000 722.002.000
86.2%
-- --
--
-- --
--
ende